OneMedNet (ONMD) Fundamental Analysis: Revenue, Earnings & Valuation

1.51 / 10

Underperform

Fundamentally, ONMD is underperforming with a 1.5/10 rating. Strengths lie in interest coverage (6.75) and fixed‑asset turnover (5.57), but cash‑to‑market, ROE (‑31%) and cash‑MV are poor, indicating limited financial resilience.

Analysis Checks(4/10)

Net assets per share (growth rate compared to beginning of year %)

Value86.10

Score2/3

Weight2.88%

1M Return-0.89%

Annualized return on equity (%)

Value-41.75

Score0/3

Weight16.15%

1M Return-6.47%

Quick ratio

Value2.20

Score0/3

Weight9.63%

1M Return-3.43%

Fixed assets turnover ratio

Value5.57

Score2/3

Weight3.69%

1M Return-1.28%

Long-term debt to working capital ratio (%)

Value26.96

Score2/3

Weight8.53%

1M Return-3.64%

Interest coverage ratio (EBIT / Interest expense) (%)

Value6.75

Score2/3

Weight8.20%

1M Return-3.03%

Asset-MV

Value-0.49

Score1/3

Weight11.52%

1M Return-5.03%

ROE (%)

Value-31.31

Score0/3

Weight16.15%

1M Return-6.47%

Current assets / Total assets (%)

Value96.02

Score1/3

Weight8.51%

1M Return-3.34%

Cash-MV

Value-0.09

Score0/3

Weight14.75%

1M Return-8.60%

Is ONMD undervalued or overvalued?

ONMD scores 1.51/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -411.74% net margin, -22.32 P/E ratio, -11.52 P/B ratio, and -102.29% earnings growth, these metrics solidify its Underperform investment rating.